These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 27035096

  • 21. Curcumin sensitizes human lung cancer cells to apoptosis and metastasis synergistically combined with carboplatin.
    Kang JH, Kang HS, Kim IK, Lee HY, Ha JH, Yeo CD, Kang HH, Moon HS, Lee SH.
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1416-25. PubMed ID: 25716014
    [Abstract] [Full Text] [Related]

  • 22. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
    Yang L, Mashima T, Sato S, Mochizuki M, Sakamoto H, Yamori T, Oh-Hara T, Tsuruo T.
    Cancer Res; 2003 Feb 15; 63(4):831-7. PubMed ID: 12591734
    [Abstract] [Full Text] [Related]

  • 23. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC, Bathina M, Fiscus RR.
    J Cell Biochem; 2012 Nov 15; 113(11):3587-98. PubMed ID: 22740515
    [Abstract] [Full Text] [Related]

  • 24. Iressa strengthens the cytotoxic effect of docetaxel in NSCLC models that harbor specific molecular characteristics.
    Rosetti M, Zoli W, Tesei A, Ulivi P, Fabbri F, Vannini I, Brigliadori G, Granato AM, Amadori D, Silvestrini R.
    J Cell Physiol; 2007 Sep 15; 212(3):710-6. PubMed ID: 17458894
    [Abstract] [Full Text] [Related]

  • 25. Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells.
    Liu JT, Li WC, Gao S, Wang F, Li XQ, Yu HQ, Fan LL, Wei W, Wang H, Sun GP.
    Clin Lung Cancer; 2015 Sep 15; 16(5):e55-66. PubMed ID: 25979647
    [Abstract] [Full Text] [Related]

  • 26. Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer.
    Howe GA, Xiao B, Zhao H, Al-Zahrani KN, Hasim MS, Villeneuve J, Sekhon HS, Goss GD, Sabourin LA, Dimitroulakos J, Addison CL.
    PLoS One; 2016 Sep 15; 11(3):e0150567. PubMed ID: 26962872
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Proteasome inhibition with bortezomib enhances activity of topoisomerase I-targeting drugs by NF-kappaB-independent mechanisms.
    Takigawa N, Vaziri SA, Grabowski DR, Chikamori K, Rybicki LR, Bukowski RM, Ganapathi MK, Ganapathi R, Mekhail T.
    Anticancer Res; 2006 Sep 15; 26(3A):1869-76. PubMed ID: 16827119
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Human non‑small cell lung cancer cells can be sensitized to camptothecin by modulating autophagy.
    Chiu YH, Hsu SH, Hsu HW, Huang KC, Liu W, Wu CY, Huang WP, Chen JY, Chen BH, Chiu CC.
    Int J Oncol; 2018 Nov 15; 53(5):1967-1979. PubMed ID: 30106130
    [Abstract] [Full Text] [Related]

  • 31. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
    Zhu K, Fang W, Chen Y, Lin S, Chen X.
    Oncol Rep; 2014 Sep 15; 32(3):1234-42. PubMed ID: 25017445
    [Abstract] [Full Text] [Related]

  • 32. Synergistic antitumor activity of pro-apoptotic agent PAC-1 with cisplatinum by the activation of CASP3 in pulmonary adenocarcinoma cell line H1299.
    Huang JQ, Liang HL, Zhang XC, Xie Z, Jin TE.
    Asia Pac J Clin Oncol; 2016 Mar 15; 12(1):41-51. PubMed ID: 26620316
    [Abstract] [Full Text] [Related]

  • 33. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
    Yu C, Krystal G, Varticovksi L, McKinstry R, Rahmani M, Dent P, Grant S.
    Cancer Res; 2002 Jan 01; 62(1):188-99. PubMed ID: 11782377
    [Abstract] [Full Text] [Related]

  • 34. Antiproliferative and antimetastatic action of quercetin on A549 non-small cell lung cancer cells through its effect on the cytoskeleton.
    Klimaszewska-Wiśniewska A, Hałas-Wiśniewska M, Izdebska M, Gagat M, Grzanka A, Grzanka D.
    Acta Histochem; 2017 Mar 01; 119(2):99-112. PubMed ID: 27887793
    [Abstract] [Full Text] [Related]

  • 35. Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways.
    Janmaat ML, Kruyt FA, Rodriguez JA, Giaccone G.
    Clin Cancer Res; 2003 Jun 01; 9(6):2316-26. PubMed ID: 12796401
    [Abstract] [Full Text] [Related]

  • 36. Isorhamnetin flavonoid synergistically enhances the anticancer activity and apoptosis induction by cis-platin and carboplatin in non-small cell lung carcinoma (NSCLC).
    Zhang BY, Wang YM, Gong H, Zhao H, Lv XY, Yuan GH, Han SR.
    Int J Clin Exp Pathol; 2015 Jun 01; 8(1):25-37. PubMed ID: 25755690
    [Abstract] [Full Text] [Related]

  • 37. Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells.
    Hajji N, Wallenborg K, Vlachos P, Nyman U, Hermanson O, Joseph B.
    Oncogene; 2008 May 15; 27(22):3134-44. PubMed ID: 18071312
    [Abstract] [Full Text] [Related]

  • 38. Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells.
    Della Corte CM, Ciaramella V, Di Mauro C, Castellone MD, Papaccio F, Fasano M, Sasso FC, Martinelli E, Troiani T, De Vita F, Orditura M, Bianco R, Ciardiello F, Morgillo F.
    Oncotarget; 2016 Jan 26; 7(4):4265-78. PubMed ID: 26673006
    [Abstract] [Full Text] [Related]

  • 39. Phloretin induces apoptosis of non-small cell lung carcinoma A549 cells via JNK1/2 and p38 MAPK pathways.
    Min J, Huang K, Tang H, Ding X, Qi C, Qin X, Xu Z.
    Oncol Rep; 2015 Dec 26; 34(6):2871-9. PubMed ID: 26503828
    [Abstract] [Full Text] [Related]

  • 40. Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment.
    Gatti L, Cossa G, Tinelli S, Carenini N, Arrighetti N, Pennati M, Cominetti D, De Cesare M, Zunino F, Zaffaroni N, Perego P.
    J Pharmacol Exp Ther; 2014 Mar 26; 348(3):360-71. PubMed ID: 24345465
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.